精华制药10月16日获融资买入310.34万元，融资余额1.63亿元

Core Insights - On October 16, Jinghua Pharmaceutical's stock price remained unchanged at 0.00%, with a trading volume of 70.49 million yuan [1] - The company experienced a net financing outflow of 5.15 million yuan on the same day, with a total financing balance of 163 million yuan, representing 2.74% of its market capitalization [1] - As of June 30, 2025, Jinghua Pharmaceutical reported a revenue of 731 million yuan, a year-on-year increase of 1.54%, while its net profit attributable to shareholders decreased by 3.54% to 131 million yuan [2] Financing and Margin Trading - On October 16, the financing buy amount for Jinghua Pharmaceutical was 3.10 million yuan, with a total financing balance of 163 million yuan, which is below the 40th percentile of the past year [1] - The company had a margin trading balance of 67,400 yuan, with a short selling volume of 0 shares on October 16, indicating low activity in this area [1] Shareholder Structure - As of June 30, 2025, the number of shareholders for Jinghua Pharmaceutical was 95,900, a decrease of 5.29% from the previous period, while the average number of circulating shares per person increased by 5.58% to 8,492 shares [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 4.48 million shares to 8.53 million shares, while the Huatai-PineBridge CSI Traditional Chinese Medicine ETF reduced its holdings by 243,700 shares to 2.68 million shares [3]